Imio
Chicago, US · Founded 2023 · 11 employees on LinkedIn · 3 known investors
Imio makes Re-Gen, a freeze-dried microbial powder applied to crop residue for row crops such as corn, helping farmers unlock NPK nutrient value and increase yields. The product is aimed at agricultural growers seeking fertilizer savings and higher output per acre.
Founders & leadership
Imio was founded in 2023 by Charles Frederick Smith.
CF
Charles Frederick SmithFounder
Board
JB
Jeremiah BrewerBoard director
GB
Guillaume BaxterBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2026
▶$6MraisedJul 2026 · 8 investors · Other TechnologyRule 506(b)
▶$6MraisedJul 2026 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
- Charles Frederick SmithExecutive Officer, Director, Promoter
- Jeremiah BrewerDirector
- Guillaume BaxterDirector
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapMiLaboratories4 shared keywordsUS-based AI-driven data intelligence platform for drug discovery and computational biology.
Mimio Health4 shared keywordsMimio makes a daily supplement built from fasting metabolites that aims to recreate the cellular health and longevity benefits of prolonged fasting without requiring users to fast. The consumer product is positioned around autophagy support, healthy aging, appetite control, and metabolic health.
miDiagnostics4 shared keywordsmiDiagnostics develops a portfolio of molecular diagnostic tests focused on speed, accuracy, and quality to support healthcare professionals at the point of care. Its products aim to bring high-quality testing closer to patients in settings such as clinics, nursing homes, and home care.
bio4 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Mahmi Bio3 shared keywordsA company using artificial intelligence to identify natural proteins of interest, operating at the intersection of foodtech, immunology, and biotech.
Companies competing with Imio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Imio do?
- Imio makes Re-Gen, a freeze-dried microbial powder applied to crop residue for row crops such as corn, helping farmers unlock NPK nutrient value and increase yields. The product is aimed at agricultural growers seeking fertilizer savings and higher output per acre.
- Who founded Imio?
- Imio was founded by Charles Frederick Smith in 2023.
- Who are Imio's investors?
- Imio's investors include Starshot, Workshop Venture Partners, Serra Ventures.
- How much funding has Imio raised?
- Imio has disclosed $6M raised across 1 round.
- Where is Imio headquartered?
- Imio is headquartered in Chicago, US.